Table 3. Combination of PARP6 and Survivin expression and its correlation with Clinico-pathological features in CRC.
PARP6 expression Survivin expression |
Low High |
High High |
Low Low |
High Low |
P-value |
---|---|---|---|---|---|
Total | 61 | 26 | 61 | 90 | |
Age (years) | |||||
≥50 | 54 | 25 | 56 | 86 | |
<50 | 7 | 1 | 5 | 4 | |
Sex | |||||
Male | 30 | 16 | 40 | 54 | |
Female | 31 | 10 | 21 | 36 | |
Tumor size (mm) | |||||
≥50 | 24 | 15 | 27 | 33 | |
<50 | 37 | 11 | 34 | 58 | |
Histological differentiation | |||||
Por/Muc | 25 | 2 | 17 | 4 | <0.01 |
W/M | 36 | 24 | 44 | 86 | |
Lymph node metastasis | |||||
Negative | 15 | 11 | 35 | 64 | <0.01 |
Positive | 46 | 15 | 26 | 26 | |
Lymphatic invasion | |||||
Negative | 3 | 2 | 7 | 14 | |
Positive | 58 | 24 | 54 | 76 | |
Venous invasion | |||||
Negative | 9 | 6 | 19 | 23 | |
Positive | 52 | 20 | 42 | 67 | |
Tumor stage | |||||
BC | 34 | 19 | 48 | 87 | <0.01 |
D | 27 | 7 | 13 | 3 |